Cargando…
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
BACKGROUND: Fibroblast growth factors (FGFs) and their receptors (FGFRs) play a crucial role in cell fate and angiogenesis, with dysregulation of the signaling axis driving tumorigenesis. Therefore, many studies have targeted FGF/FGFR signaling for cancer therapy and several FGFR inhibitors have pro...
Autores principales: | Ruan, Ruiwen, Li, Li, Li, Xuan, Huang, Chunye, Zhang, Zhanmin, Zhong, Hongguang, Zeng, Shaocheng, Shi, Qianqian, Xia, Yang, Zeng, Qinru, Wen, Qin, Chen, Jingyi, Dai, Xiaofeng, Xiong, Jianping, Xiang, Xiaojun, Lei, Wan, Deng, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039534/ https://www.ncbi.nlm.nih.gov/pubmed/36966334 http://dx.doi.org/10.1186/s12943-023-01761-7 |
Ejemplares similares
-
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012) -
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
por: Roussot, Nicolas, et al.
Publicado: (2023) -
FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes
por: Furugaki, Koh, et al.
Publicado: (2023) -
FGF/FGFR signaling in health and disease
por: Xie, Yangli, et al.
Publicado: (2020) -
Expression Atlas of FGF and FGFR Genes in Pancancer Uncovered Predictive Biomarkers for Clinical Trials of Selective FGFR Inhibitors
por: Li, Yuan, et al.
Publicado: (2020)